Highlights ARYA Sciences Acquisition Corp IV

Equities

ARYD

KYG316591083

Market Closed - Nasdaq Other stock markets 02:00:00 14/05/2024 am IST			5-day change	1st Jan Change
11.37 ^USD	+0.18%		0.00%	+4.31%

29/03	ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	CI
08/02	ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022	07/23/07	CI
ARYA Sciences Acquisition IV : Non-Reliance on Previously Issued Financial Report - Form 8-K	05/23/05	PU
ARYA SCIENCES ACQUISITION CORP IV : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	05/23/05	AQ
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/22/08	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	08/22/08	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31	CI
Amicus Therapeutics Loss Narrows, Revenue Rises in 2021; Terminates ARYA Sciences Combination Over Market Conditions	24/22/24	MT
Gene Therapy Business of Amicus Therapeutics, Inc. cancelled the acquisition of ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.	23/22/23	CI
ARYA Sciences Acquisition IV : As discussed in Note 2 to the financial statement, the March 2, 2021 financial statement has been restated to correct a certain misstatement - Form 8-K/A	14/22/14	PU
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	13/21/13	CI
ARYA Sciences Acquisition Corp IV Provides Earnings Guidance for the Year 2021	09/21/09	CI
Amicus Therapeutics : and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company, 'Caritas Therapeutics'	30/21/30	AQ
ARYA Sciences Acquisition IV : Business Combination of Amicus Gene Therapy Business with ARYA IV to Result in the Launch of Caritas Therapeutics, a New Independent, Publicly Traded Company with Expected ~$400M in Initial Funding (Form 8-K)	29/21/29	PU
Amicus Therapeutics : Arya Sciences Acquisition Corp to Create Genetic Medicine Company Caritas Therapeutics	29/21/29	MT
Gene Therapy Business of Amicus Therapeutics, Inc. entered into a non-binding agreement to acquire ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.	29/21/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ARYA Sciences Acquisition Corp IV

Equities

ARYD

KYG316591083

Highlights

Filters